Yintoni umahluko phakathi kwe-antiplatelet kunye ne-anti coagulation?


Umbhali: Ophumeleleyo   

I-Anticoagulation yinkqubo yokunciphisa ukubunjwa kwe-fibrin thrombus ngokusetyenziswa kweziyobisi ze-anticoagulant ukunciphisa inkqubo ye-intrinsic pathway kunye ne-intrinsic coagulation pathway.

Iyeza elichasayo kukuthatha iziyobisi ezichasene neplatelet ukunciphisa ukunamathela kunye nomsebenzi wokudibanisa iiplatelet, ngaloo ndlela ukunciphisa inkqubo yokwakheka kweplatelet thrombus.Kwinkqubo yeklinikhi, iziyobisi ezisetyenziswa ngokuqhelekileyo ze-anticoagulant ziquka i-warfarin kunye ne-heparin, enciphisa ithuba lokwakheka kwe-fibrinogen thrombus ngeendlela ezahlukeneyo ze-anticoagulant.Ngokomzekelo, i-warfarin idla ngokusetyenziswa kunyango lwe-anticoagulant emva kotyando lwevalvu yentliziyo, kwaye i-heparin isetyenziswa rhoqo kunyango lwe-thrombosis ye-venous esezantsi.

Izidakamizwa eziqhelekileyo ze-antiplatelet ziquka i-aspirin, i-Plavix, njl. La machiza anokuthintela ukuhlanganiswa kweplatelet ngokusebenzisa izixhumanisi ezahlukeneyo, ngaloo ndlela ukuthintela ukubunjwa kwe-platelet thrombus.Ngokonyango, isetyenziselwa ukuthintela isifo senhliziyo, isifo se-cerebral thrombosis kunye nezinye izifo.

I-Beijing SUCCEEDER njengenye yeebrendi eziphambili kwimarike ye-China Diagnostic ye-Thrombosis kunye ne-Hemostasis, i-SUCCEEDER inamava ngamaqela e-R&D, iMveliso, iNtengiso yeNtengiso kunye noBonelelo lweNkonzo yokuHlalutya i-coagulation kunye ne-reagents, abahlalutyi be-rheology yegazi, i-ESR kunye nabahlalutyi be-HCT, i-platelet aggregation ne-ISO148zer , Isiqinisekiso seCE kunye ne-FDA edwelisiweyo.